---

Feed Intolerance in Neonates - A Structured Approach for the DM Neonatology Resident

---

1. DEFINITION & SCOPE

• Large/abnormal gastric residuals (GRVs)
• Bilious or bloody aspirates
• Abdominal distension
• Vomiting/regurgitation
• Bloody stools
• Feed-associated apnea/bradycardia

Key principle: Up to 50% of all preterm infants manifest some form of feed intolerance during their NICU course, but <25% of those will develop NEC. Your task is to risk-stratify and not over-react OR under-react.

---

2. PATHOPHYSIOLOGY - WHY NEONATES GET FEED INTOLERANCE

Gut Immaturity (most common cause, especially preterm)

• Decreased GI motility (poor antroduodenal coordination, decreased MMC)
• Delayed gastric emptying
• Immature lower esophageal sphincter tone
• Reduced digestive enzyme activity (lactase, lipase)
• Impaired gut hormonal response (motilin, ghrelin)
• Thin mucus layer, immature tight junctions - increased permeability

Dysbiosis

• Preterm gut lacks commensal colonization
• NICU exposures (antibiotics, formula) shift microbiome toward pathogenic taxa
• Feeds are the main driver of commensal colonization - hence the value of breast milk

NEC Pathogenesis (the extreme end)

• Immature gut + dysbiosis + injurious luminal trigger (formula, rapid feed advancement)
• Exaggerated inflammatory response - TLR4 overactivation
• Mucosal ischemia -> transmural necrosis
• Peak incidence at ~32 weeks post-menstrual age (inversely related to GA at birth)
• Incidence: 4-13% in VLBW infants; mortality 10-30% (up to 50% if surgical)

---

3. CAUSES - DIFFERENTIAL APPROACH

A. Gut-intrinsic, benign

B. Gut-intrinsic, serious

C. Systemic (extra-intestinal) - "sick gut from sick baby"

---

4. CLINICAL ASSESSMENT - THE BEDSIDE EVALUATION

History

• GA, birth weight, age in days/weeks, corrected age
• Type of feed (own mother's milk, donor milk, formula, hydrolysate)
• Current feed volume and rate of advancement
• Time of last stool
• Antenatal: corticosteroids, indomethacin tocolysis, IUGR, absent/reversed end-diastolic flow
• Postnatal events: sepsis, antibiotics, blood transfusions (PRBC transfusion is a NEC trigger - consider holding feeds peri-transfusion), PDA, respiratory status

Physical Examination - the ABCDE of abdomen in neonates

• Abdomen: distension? Visible loops? Erythema/edema of abdominal wall (NEC alarm sign)
• Bowel sounds: absent = ileus/NEC; hyperactive = obstruction
• Color of aspirate (described below)
• Defecation: last stool, consistency, blood
• Endoscopy of the body: systemic signs - temperature instability, apnea, bradycardia, HR trend, perfusion, capillary refill

Gastric Residual Evaluation

---

5. INVESTIGATIONS

Tier 1 (always in significant FI):

• KUB X-ray (supine + left lateral decubitus) - look for:
  • Generalized gaseous distension
  • Pneumatosis intestinalis (intramural gas) - pathognomonic NEC
  • Portal venous gas - advanced NEC
  • Pneumoperitoneum (decubitus view) - perforation = surgical emergency
  • Dilated loop with fixed position (serial X-rays every 6-8 hours if NEC suspected)
  • "Gasless abdomen" in sick baby - ascites, or so much ileus that gas is absent
• CBC with differential - neutropenia or left shift + thrombocytopenia = ominous
• Blood culture (before antibiotics)
• CRP (rises later, 12-24h lag; serial CRP more useful)
• Blood gas - metabolic acidosis is a poor prognostic sign in NEC
• Serum electrolytes, glucose, calcium

Tier 2 (selective):

• Serial X-rays every 6-8h if NEC or perforation suspected
• Abdominal ultrasound - more sensitive than X-ray for portal venous gas, free fluid, bowel wall thickness and perfusion; operator-dependent
• Stool occult blood
• TFTs, metabolic screen if chronic/recurrent FI
• Urine + LP if sepsis suspected (systemic signs)
• Contrast enema (water-soluble) if Hirschsprung or distal obstruction suspected - NOT during active NEC
• Rectal biopsy for Hirschsprung (acetylcholinesterase staining, suction biopsy preferred)
• Eosinophil count, IgE, RAST if milk protein allergy suspected

---

6. RISK STRATIFICATION - The NEC Red Flags

Clinical features that should trigger NEC workup:

• Abdominal wall discoloration (erythema, blue-purple hue) - late sign, means advanced NEC
• Visible bowel loops or palpable mass
• Absent bowel sounds
• Tenderness on palpation (neonates show this by grimacing, increased tone)
• Bilious aspirates with abdominal distension
• Bloody stools with systemic signs
• Temperature instability + new abdominal signs
• Recent PRBC transfusion (within 48h)

Bell's Staging (classic but still used):

---

7. MANAGEMENT

A. Benign Feed Intolerance (gut immaturity, dysmotility)

• Continue feeds at current rate; do not advance
• Return clear/milky aspirate
• Consider positioning (semi-prone or right lateral after feeds)
• Ensure OGT/NGT position confirmed
• Continuous feeds vs bolus feeds: continuous feeds may be better tolerated in very preterm infants
• Trial of smaller more frequent boluses
• Prokinetics: Evidence is weak; domperidone and metoclopramide carry risks (domperidone - QTc prolongation; metoclopramide - extrapyramidal effects). Erythromycin (low dose 3-5 mg/kg/dose 4x/day) is a motilin receptor agonist and may help in true gut dysmotility - use selectively, not routinely.

B. NEC Stage I - Suspected (Bell's I)

• NPO (nil per os)
• IV fluid maintenance + replace for third-spacing
• KUB X-ray; baseline investigations as above
• Serial abdominal examinations every 4-6 hours
• Blood cultures before antibiotics
• Antibiotics: Ampicillin (or penicillin) + Gentamicin ± Metronidazole (for anaerobic coverage)
• Monitor: HR, BP, SpO2, urine output, serial X-rays (6-8 hourly)
• If no deterioration and improvement in 48-72h, cautious restart of feeds at ~72h

C. NEC Stage II - Definite

• Strict NPO for 7-10 days
• IV fluids; consider colloid (albumin/FFP) if significant third-spacing
• TPN via central line (PICC/UVC)
• Nasogastric decompression (free drainage + aspiration 4-hourly)
• Antibiotics for 10-14 days (adjust based on cultures)
• Serial KUBs every 6-8 hours
• Hematology support: FFP for DIC, platelet transfusion if <50,000 + active bleeding or <100,000 + planning surgery
• Pediatric surgery consult at Stage II

D. NEC Stage III / Surgical NEC

• Pneumoperitoneum (perforation)
• Intestinal gangrene (fixed dilated loop >24h, portal venous gas, progressive clinical deterioration)
• Clinical deterioration despite maximal medical therapy

• Peritoneal drain (especially in ELBW <1000g, hemodynamically unstable - as bridge or definitive)
• Exploratory laparotomy with resection of necrotic bowel + primary anastomosis or stoma

E. Special Scenarios

• Switch to extensively hydrolyzed formula (eHF) or amino acid formula (AAF)
• Mother's diet restriction if breastfed
• Reintroduce after 4-6 weeks with challenge

• Distinct from NEC: no pneumatosis, usually ELBW, first week, associated with steroids + indomethacin
• Management: peritoneal drain or surgery
• Better prognosis than surgical NEC

• Rectal washouts for decompression
• Staged surgical repair: leveling colostomy then Soave/Swenson/Duhamel pull-through
• HAEC: broad-spectrum IV antibiotics + rectal washouts urgently

---

8. FEEDING STRATEGIES TO PREVENT FEED INTOLERANCE

Minimal Enteral Nutrition (MEN / Gut Priming)

• Rationale: even tiny volumes stimulate gut hormonal development, colonization, and mucosal integrity
• Start: Day 1-2 of life in stable preterm infants (even on ventilator)
• Volume: 10-20 mL/kg/day for 3-5 days before advancing
• Evidence: reduces time to full feeds, reduces cholestasis, no increase in NEC

Feed Advancement Rates

• VLBW (<1500g): Advance by 15-20 mL/kg/day
• ELBW (<1000g) or high-risk: 10-15 mL/kg/day or slower
• Target full enteral feeds: 150-180 mL/kg/day
• SIFT trial: faster advancement (30 mL/kg/day) was safe in VLBW, but most NICUs remain cautious

Feed Type

• Own mother's colostrum - oropharyngeal colostrum (OPC) from day 1 even before enteral feeds
• Own mother's milk (OMM) is the gold standard; reduces NEC 4-fold
• Donor human milk (DHM) - protective vs formula if OMM unavailable; pasteurization reduces some bioactive components
• Preterm formula if no human milk available
• Fortification: Add human milk fortifier once at ~100 mL/kg/day (not before, as higher osmolality may increase NEC risk)

Probiotics

• Network meta-analysis (Wang et al., JAMA Pediatr 2023, PMID 37782505): Lactobacillus rhamnosus + Bifidobacterium longum combination showed best evidence for reducing NEC + mortality in preterm infants
• Current uncertainty: strain selection, dose, duration, safety in ELBW; no universal guideline; use center-specific protocol
• Probiotics + lactoferrin combination shows synergistic benefit in some trials

Hold-Feed Triggers (conservative but evidence-based)

• Bilious or bloody aspirate with clinical signs
• Abdominal distension + absent bowel sounds
• Any systemic deterioration attributable to feeding
• Peri-transfusion period: many centers hold feeds for 12-24h before and after PRBC transfusion (controversy remains; some RCTs in progress)

---

9. MONITORING AFTER RESTARTING FEEDS POST-NEC

• Restart feeds only after:
  • Clinical improvement (no systemic signs)
  • Tolerating NG decompression without bilious aspirates
  • Normal serial X-rays for 48-72h
  • CRP trending down
• Restart at trophic volumes (10-20 mL/kg/day)
• Advance very slowly (10 mL/kg/day increments)
• Watch for post-NEC strictures (typically at 4-6 weeks): rebound abdominal distension, intolerance, rectal bleeding - contrast enema diagnostic

---

10. QUICK REFERENCE - DECISION ALGORITHM

Feed Intolerance Noted
         |
    Is baby UNWELL? (HR, SpO2, temp, BP, perfusion)
         |                |
        YES              NO
         |                |
   STOP FEEDS         Assess aspirate color/volume
   KUB + Labs         |              |
   Blood culture    CLEAR/MILKY   BILIOUS/BLOODY
   Antibiotics      Benign cause   STOP + URGENT REVIEW
   Surgery if        likely         KUB + NEC workup
   pneumoperit.     Continue/
                    Slow advance

---

11. HIGH-YIELD EXAM POINTS FOR DM NEONATOLOGY

---

• Creasy & Resnik's Maternal-Fetal Medicine, 8e - NEC chapter (pp. 1790+)
• Branagan A et al. GRASS trial. Eur J Pediatr 2024 - PMID 38427039 (GRV assessment delays full feeds)
• Wang Y et al. JAMA Pediatr 2023 - PMID 37782505 (Probiotics network meta-analysis)
• Hu X et al. Pediatr Surg Int 2024 - PMID 38196049 (NEC prevention and management review)
• Risk-Stratified Enteral Feeding on NICU Guideline, Ashford St Peters, Oct 2024